• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Nationwide treatment regimen more than halves tuberculosis prevalence in China

byMelissa McCoyandAndrew Bishara
March 21, 2014
in Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Over a 20-year period, China reduced prevalence of smear-positive tuberculosis by more than half by shifting tuberculosis treatment from hospitals to public health centers that implemented the directly observed treatment, short-course (DOTS) strategy.

2. The directly observed treatment, short-course (DOTS) regimen was particularly effective at reducing prevalence of known cases of tuberculosis, implying that overall prevalence decrease was primarily due to better treatment rather than by earlier diagnosis of tuberculosis.

Evidence Rating Level: 2 (Good)

Study Rundown: In the 1990s, China extended tuberculosis control to half the population by providing directly observed treatment, short-course (DOTS). By 2000, DOTS was available to the entire population. This study assessed the impact of the DOTS scale-up over a 20-year period. Results of three national tuberculosis prevalence surveys from 1990, 2000, and 2010 were analyzed. In the 1990s, smear-positive disease prevalence decreased only in provinces that had implemented DOTS. After 2000, prevalence was decreased in all provinces, paralleling the extended implementation of DOTS. Overall, smear-positive prevalence fell by 65%. This study’s findings are strengthened by the large sample size and geographical area, which ensured a more accurate national representation of the population. A limitation of this study was that in 1990 and 2000, chest fluoroscopy was used for screening and in 2010 chest radiography was used. Due to the increased sensitivity of radiography reduction of pulmonary cases may have been masked.

Click to read the study in The Lancet

Relevant Reading: Progress in tuberculosis control and the evolving public-health system in China

RELATED REPORTS

Intravenous fluid restriction does not improve septic shock outcomes

RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection

Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

In-Depth [prospective study]: This study analyzed longitudinal data from the 1990, 2000, and 2010 national tuberculosis prevalence surveys in China. Individuals 15 years and older from 31 provinces were screened with chest imaging, and those with abnormal imaging findings and/or persistent cough were classified as having suspected tuberculosis. Results were confirmed with chest radiography, sputum-smear, and culture. From 1990 to 2010 smear-positive tuberculosis prevalence fell from 170 cases (95% CI 166-174) to 59 cases (49-72) per 100,000 population. 68 (87%) of these cases were known cases (diagnosed before the survey) comprised the majority of the reduction in overall prevalence. From 1990 to 2000 programmatic changes were minimal. Reporting of cases to the CDC system increased from 460 (19%) of 2453 to 93 (23%) of 374 (p=0.0055), and the proportion of patients who received tuberculosis treatment increased from 2313 (94%) of 2453 to 370 (99%) of 374 (p=0.00014.)

More from this author: Estimated three quarters of people with influenza are asymptomatic [Flu Watch study], Rotavirus vaccine 116E shown effective and affordable in India, Nursing staff cuts associated with increased risk of preventable deaths, Estimated 1 in 14 women worldwide survivors of sexual violence in lifetime

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: chinaDOTSinfectious diseaseprevalencestudytreatmenttuberculosis
Previous Post

Stool DNA testing may improve screening sensitivity of colorectal cancer

Next Post

Cesarean in the second stage associated with endometritis

RelatedReports

Hypotonic IVF linked to increased risk of hyponatremia
Emergency

Intravenous fluid restriction does not improve septic shock outcomes

June 27, 2022
RSV positivity associated with reduced serious bacterial infection risk [Classics Series]
Infectious Disease

RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection

June 24, 2022
Masks for personal protection for SARS-CoV-2 infection
Infectious Disease

Molnupiravir improves outcomes in non-hospitalized COVID-19 patients

June 23, 2022
Reduced doses of human papillomavirus vaccine may be effective in preventing condyloma
Public Health

Human papillomavirus vaccine effective in preventing infections in the United States

June 23, 2022
Next Post
Obtaining consent for c-section during labor may be suboptimal

Cesarean in the second stage associated with endometritis

Patients with late stage melanoma remain at risk for further primary melanoma

Initial primary invasive or in situ melanoma increases risk of subsequent invasive melanoma

ADHD stimulant treatment associated with changes in BMI trajectory

Child activity levels correlate with mothers’ activity levels

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma
  • Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency
  • Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.